Hostile takeover: glioma stem cells recruit TAMs to support tumor progression

Yu Shi1, Yi-fang Ping1, Xia Zhang1

  • 1Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, Chongqing 400038, China; Key Laboratory of Tumor Immunopathology of Ministry of Education of China, Third Military Medical University, Chongqing 400038, China.

Cell Stem Cell
|March 10, 2015
PubMed

Insights

Glioma stem cells secrete Periostin (POSTN), attracting tumor-associated macrophages (TAMs). This interaction promotes the M2 subtype, crucial for understanding tumor immunotherapy development.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • The interaction between cancer and immune cells is vital for effective tumor immunotherapies.
  • Glioma stem cells (GSCs) play a significant role in tumor progression and immune evasion.

Purpose of the Study:

  • To investigate the role of glioma stem cells in recruiting immune cells.
  • To identify specific molecules secreted by GSCs that influence the tumor microenvironment.

Main Methods:

  • Analysis of gene expression in glioma stem cells.
  • Immunohistochemistry to detect Periostin and macrophage markers in tumor tissues.
  • Co-culture experiments to assess the effect of GSC-secreted factors on macrophage polarization.

Main Results:

  • Glioma stem cells were found to secrete Periostin (POSTN).
  • Periostin was shown to recruit tumor-associated macrophages (TAMs) to the tumor site.
  • Recruited TAMs were predominantly of the M2 subtype, which is associated with tumor promotion.

Conclusions:

  • Glioma stem cells utilize Periostin to shape the immune microenvironment.
  • The POSTN-mediated recruitment of M2 TAMs by GSCs represents a potential therapeutic target for glioma immunotherapy.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.2K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.4K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
7.0K